The number of private equity-driven deals in gastroenterology — including add-on, platform and growth deals — decreased by half between 2022 and 2023.
|
Type of Deal |
2020 |
2021 |
2022 |
2023 |
|
Total |
15 |
34 |
26 |
13 |
|
Add-on |
12 |
31 |
22 |
10 |
|
Platform |
3 |
1 |
2 |
1 |
|
Growth |
N/A |
2 |
2 |
2 |
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.